Concepedia

Emeline Boët

EB

Statistics

Publications

11

Citations

598

H-Index

11

Active since

2020

Affiliations

Centre de Recherches en Cancérologie de Toulouse(Current)

Inserm

Université Fédérale de Toulouse Midi-Pyrénées

La Ligue Contre le Cancer

Institut universitaire du cancer de Toulouse Oncopole

Emeline Boët is an author at Centre de Recherches en Cancérologie de Toulouse specializing in acute myeloid leukemia biology, acute myeloid leukemia therapy, and oncology.

ORCID

Publications per year

2020–2024

11

Publications

11

Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia

Lucille Stuani, Marie Sabatier, Estelle Saland et al. · The Journal of Experimental Medicine · 2021 · 122 citations · Full text

, , +17

Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia

Claudie Bosc, Estelle Saland, Aurélie Bousard et al. · Nature Cancer · 2021 · 114 citations

, , +17

C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress–Induced Ferroptosis in <i>FLT3</i> -Mutant Leukemia

Marie Sabatier, Rudy Birsen, Laura Lauture et al. · Cancer Discovery · 2023 · 90 citations · Full text

, , +17

Extracellular ATP and CD39 Activate cAMP-Mediated Mitochondrial Stress Response to Promote Cytarabine Resistance in Acute Myeloid Leukemia

Nesrine Aroua, Emeline Boët, Margherita Ghisi et al. · Cancer Discovery · 2020 · 73 citations · Full text

, , +17

Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells

Clément Larrue, Nathan Guiraud, Pierre‐Luc Mouchel et al. · Nature Communications · 2021 · 63 citations · Full text

, , +17

1–5 of 11